# DEDICA (Dose of HEparin During Coronary Angioplasty) Trial

> **NCT01694459** · PHASE4 · UNKNOWN · sponsor: **San Filippo Neri General Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Stable Angina
- Angina, Unstable
- Non-ST Elevation (NSTEMI) Myocardial Infarction

## Interventions

- **DRUG:** Low-dose heparin
- **DRUG:** Standard dose heparin

## Key facts

- **NCT ID:** NCT01694459
- **Lead sponsor:** San Filippo Neri General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2012-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694459, "DEDICA (Dose of HEparin During Coronary Angioplasty) Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01694459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*